EADV 2021 – New Long Term Bimekizumab Data
Dr. Natalie Nunez Gomez, Head of Global Medical Affairs, Psoriasis at UCB, discusses new, interim long-term results from the bimekizumab BE BRIGHT open-label extension study presented at the European Academy of Dermatology and Venereology (EADV) Congress, as well as additional findings from the Phase 3/3b clinical program for bimekizumab in psoriasis.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Natalie Nunez Gomez, Head of Global Medical Affairs, Psoriasis at UCB, discusses new, interim long-term results from the bimekizumab BE BRIGHT open-label extension study present…
- Key Point: Natalie Nunez Gomez is a Medical Doctor and is currently Head of Global Medical Affairs for psoriasis at UCB, where she leads medical strategy and scientific activities.
- Key Point: With over 17 years’ experience in the pharmaceutical industry in roles across global, US and Germany, Natalie is widely experienced in the launch of pharmaceutical products wi…
- Key Point: Prior to joining the pharmaceutical industry, Natalie also worked as a physician in the dermatology department of the Ludwig-Maximilian-University of Munich (LMU) in Germany.
- Key Point: Natalie holds a Medical Degree from the LMU in Munich, Germany.
Natalie Nunez Gomez is a Medical Doctor and is currently Head of Global Medical Affairs for psoriasis at UCB, where she leads medical strategy and scientific activities. With over 17 years’ experience in the pharmaceutical industry in roles across global, US and Germany, Natalie is widely experienced in the launch of pharmaceutical products with a specific focus in the areas of immunology and dermatology. Prior to joining the pharmaceutical industry, Natalie also worked as a physician in the dermatology department of the Ludwig-Maximilian-University of Munich (LMU) in Germany. Natalie holds a Medical Degree from the LMU in Munich, Germany.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


